In the vibrant month of March, all things flourish and renew. On March 13th, BIOCHINA 2025 (10th Edition) ENMORE Biotechnology Industry Conference was grandly held at the Suzhou International Expo Center. This exhibition featured five professional exhibition halls, serving nearly 30,000 visitors, covering 28 overseas countries and regions, empowering upstream and downstream cooperation in the domestic pharmaceutical industry, while providing a platform for domestic and international upstream and downstream cooperation and exchange.

With keen insight and forward-looking vision, Morimatsu accurately grasped the industry pulse, continued to delve into innovative technology and product development, aligned with market trends and customer needs, and presented four major solutions at this exhibition that garnered widespread attention and high praise, setting a new benchmark for industry development.

1.Total Laboratory Solution

Our offerings encompass upstream cultivation solutions and downstream separation & purification solutions, designed with robust, reliable, streamlined, and highly efficient workflows to cater to diverse experimental requirements and accelerate the translation of clients' research outcomes into tangible applications.

2.Single-Use Solution

Morimatsu's single-use systems are available in various specifications to fit multiple brands of equipment, with stable product processes, safe and reliable quality, and comprehensive validation document support.

3.Pharmadule Morimatsu's Integrated Plant Solutions

Morimatsu's modular plant offers a turnkey total solution from design to validation, saving time in constructing new factory buildings and significantly reducing on-site construction. This enables overall off-site relocation of the building, meeting pharmaceutical companies' needs for rapid product launches and flexible production expansion.

4.Morimatsu Virtual Factory Digital Twin System

Morimatsu's virtual factory is an intelligent system based on the deep integration of VR simulation and digital twin technology, truly replicating physical factories, virtualizing process knowledge, equipment operation, job training, accident handling, and other scenarios, empowering enterprise development.

During the event, Morimatsu engaged in business negotiations with industry peers, shared the latest research results and practical experiences, discussed key technical points and frontier trends in the biopharmaceutical field, and explored new potentials and opportunities. At the same time, Morimatsu listened to and absorbed valuable customer feedback from multiple perspectives, strengthened overseas project cooperation and business expansion, and sought new paths for common development.

The global biopharmaceutical industry has shown a more vigorous trend in technological innovation, deep integration of the industrial chain, and internationalization. Relying on its profound technical accumulation, Morimatsu solves core customer pain points, continuously launches more high-quality products and innovative technical solutions, actively promotes the sustainable development and transformation and upgrading of the industry, and injects strong momentum into the innovation and breakthrough of the global pharmaceutical field.

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services. 

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacture plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.   

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.